Bleomycin Powder, For Solution
Product Images NDC 16714-886

5 FDA label images from Northstar Rx Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Bleomycin (NDC 16714-886). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Formula (Ble07 0002 01)

Chemical Formula (Ble07 0002 01)
Chemical structure diagram of Bleomycin, showing the detailed molecular configuration including multiple ring structures, functional groups, and side chains, labeled with standard chemical notation.*
FDA Label Image

Principal Display Panel – Bleomycin For Injection, Usp 15 Units Per Vial Container Label (Ble07 0002 02)

Principal Display Panel – Bleomycin For Injection, Usp 15 Units Per Vial Container Label (Ble07 0002 02)
Label for Bleomycin 15 USP units per vial powder for injection by NorthStar Rx LLC. The label indicates the product is lyophilized and must be diluted for intravenous, intramuscular, subcutaneous, or intrapleural use. It is a single-dose vial and cautioned as a cytotoxic agent. Storage is recommended under refrigeration between 2° and 8°C. Manufactured by Kindos Pharmaceuticals in China.*
FDA Label Image

Principal Display Panel – Bleomycin For Injection, Usp 15 Units Per Vial Carton (Ble07 0002 03)

Principal Display Panel – Bleomycin For Injection, Usp 15 Units Per Vial Carton (Ble07 0002 03)
Packaging label for Bleomycin for Injection, USP 15 units per vial, powder for solution by NorthStar Rx LLC. The label states it must be diluted for intravenous, intramuscular, subcutaneous, or intrapleural use and cautions it is a cytotoxic agent. It includes storage instructions, manufacturer details, barcode, and states the vial is single-dose and preservative-free.*
FDA Label Image

Principal Display Panel – Bleomycin For Injection, Usp 30 Units Per Vial Container Label (Ble07 0002 04)

Principal Display Panel – Bleomycin For Injection, Usp 30 Units Per Vial Container Label (Ble07 0002 04)
Bleomycin 30 units per vial powder for injection label. The label indicates it is for intravenous, intramuscular, subcutaneous, or intrapleural use and is a single-dose vial. It includes storage instructions, cautions that it is a cytotoxic agent, and manufacturer information for NorthStar Rx LLC and Kindos Pharmaceuticals Co., Ltd.*
FDA Label Image

Principal Display Panel – Bleomycin For Injection, Usp 30 Units Per Vial Carton (Ble07 0002 05)

Principal Display Panel – Bleomycin For Injection, Usp 30 Units Per Vial Carton (Ble07 0002 05)
Bleomycin for Injection, USP 30 units per vial powder for solution label. The packaging indicates the drug must be diluted for intravenous, intramuscular, subcutaneous, or intrapleural use. It warns that the product is a cytotoxic agent and sterile, preservative-free. The labeler is NorthStar Rx LLC, with manufacturing by Kindos Pharmaceuticals Co., Ltd, China. Storage instructions specify refrigeration between 2 and 8°C. The package contains one single-dose vial.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.